PIN5 COST-EFFECTIVENESS OF DROTRECOGIN ALFA (ACTIVATED) FOR THE TREATMENT OF SEVERE SEPSIS-A CROSS-NATIONAL COMPARISON OF THREE EUROPEAN COUNTRIES
Abstract
Authors
A Neilson H Schneider H Burchardi C Chinn J Clouth A Graebe